臨床試験における人工知能（AI）の世界市場の機会と2032年までの戦略

Artificial Intelligence (AI) In Clinical Trials Global Market Opportunities And Strategies To 2032

この調査レポートは、臨床試験における人工知能（AI）の世界市場のビジネスチャンスと2032年までの戦略を掲載し、戦略家、マーケティング担当者、上級管理職がCOVID-19の閉鎖から抜け出した臨床試験における人工... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Business Research Company　(TBRC) ザ・ビジネスリサーチカンパニー	2024年1月4日	US$4,000 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	276	英語

サマリー

この調査レポートは、臨床試験における人工知能（AI）の世界市場のビジネスチャンスと2032年までの戦略を掲載し、戦略家、マーケティング担当者、上級管理職がCOVID-19の閉鎖から抜け出した臨床試験における人工知能（AI）の世界市場を評価するのに必要な重要情報を提供しています。

購入の理由
- 15の地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がコロナウイルスによってどのような影響を受けているのか、また、ウイルスの影響が和らぐにつれて市場がどのように浮上し、成長する可能性があるのかを理解する。
- 現地のデータと分析に基づき、地域別および国別の戦略を策定する。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。
- 最新の市場調査結果に基づいて顧客を理解する。
- 主要な競合他社とのパフォーマンスの比較
- 主要データセット間の関係を活用し、優れた戦略を立てる。
- 信頼性の高い高品質なデータを用いて、社内外でのプレゼンテーションをサポートします。

説明
臨床試験における人工知能（AI）の市場が最大かつ急成長しているのはどこなのか？経済全体、人口動態、その他の類似市場との関連は？今後どのような力が市場を形成していくのか？The Business Research Companyの臨床試験における人工知能（AI）市場グローバルレポートは、これらすべての質問とその他多くの質問に回答します。
当レポートでは、市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合環境、市場シェア、当市場の動向と戦略について取り上げています。地域別に市場の過去および予測成長を追跡しています。また、臨床試験における人工知能（AI）市場全体の中で同市場を位置づけ、他市場との比較も行っています。

本レポートは以下の章をカバーしています。

- 序論と市場の特徴
本レポートは、臨床試験市場における人工知能（AI）市場を、より広範な市場との関連において位置づけ、他の市場との比較を行います。
- 主要動向
世界市場を形成する主なトレンドをハイライト。また、今後の市場動向についても解説します。
- マクロ経済シナリオ
ロシア・ウクライナ戦争の影響、COVID-19パンデミックの影響、インフレ上昇が世界市場および地域市場に与える影響について分析し、臨床試験における人工知能（AI）市場におけるビジネスに戦略的洞察を提供します。
- 世界の市場規模と成長
世界の過去（2017年～2022年）および予測（2022年～2027年、2032F）の市場価値と、過去および予測期間における市場の成長を支え、制御する推進要因と抑制要因。
- 地域別および国別分析
地域別・国別の過去（2017～2022年）および予測（2022～2027年、2032F）市場価値と成長、市場シェア比較
- 市場セグメンテーション
市場における提供別、プロセス別、用途別、エンドユーザー別の市場価値（2017-2022年）（2022-2027年、2032F）および各セグメントの分析を収録。地域市場別の過去（2017-2022年）、予測（2022-2027年）、（2027-2032年）市場価値と成長率、市場シェア比較を掲載。
- 地域別市場規模と成長
地域別市場規模（2022年）、過去（2017-2022年）および予測（2022-2027,2032F）市場価値、地域内各国の成長および市場シェア比較。アジア太平洋、西欧、東欧、北米、南米、中東、アフリカの全地域と各地域内の主要国に関する情報を掲載しています。
- 競争環境
市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。
- 主要なM&A
市場における最近のM&Aに関する情報を掲載しています。近年の市場を形成したM&Aに関する主要な財務情報を掲載しています。
- 市場機会と戦略
調査結果に基づく市場機会と戦略について、国やセグメントごとの成長機会やその市場で取るべき戦略に関する情報を交えて解説しています。
- 結論と提言
臨床試験における人工知能（AI）プロバイダーに対して、製品/サービスの提供地域拡大、マーケティング戦略、ターゲットグループに関する推奨事項を記載しています。
- 付録
このセクションには、本レポートで使用したNAICSコード、略語、通貨コードの詳細が含まれています。

スコープ

対象市場
1) オファリング別ソフトウェア; サービス
2) プロセス別試験デザイン、患者選択、施設選択、患者モニタリング
3) アプリケーション別癌、神経疾患、心血管疾患、代謝性疾患、感染症、免疫疾患、その他のアプリケーション
4) エンドユーザー別：製薬・バイオテクノロジー企業、研究受託機関、その他のエンドユーザー

言及された企業Saama Technologies Inc.; Trials.Ai; Innoplexus AG; Deep 6 AI In; Unlearn.AI, Inc.

国中国、オーストラリア、インド、インドネシア、日本、韓国、米国、ブラジル、フランス、ドイツ、英国、ロシア

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年間および過去10年間の予測。

データ関連市場に対する市場規模および成長率、GDP比率、一人当たり支出、臨床試験における人工知能（AI）の指標比較。

データ区分：国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。

ページTOPに戻る

1. Executive Summary
2. Table Of Contents
3. List Of Tables
4. List Of Figures
5. Report Structure
6. Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Artificial Intelligence (AI) In Clinical Trials Market Definition And Segmentations
6.4. Market Segmentation By Offering
6.4.1. Software
6.4.2. Services
6.5. Market Segmentation By Process
6.5.1. Trial Design
6.5.2. Patient Selection
6.5.3. Site Selection
6.5.4. Patient Monitoring
6.6. Market Segmentation By Application
6.6.1. Oncology
6.6.2. Neurological Disease And Condition
6.6.3. Cardiovascular Disease
6.6.4. Metabolic Disease
6.6.5. Infectious Disease
6.6.6. Immunology Disease
6.6.7. Other Applications
6.7. Market Segmentation By End-User
6.7.1. Pharmaceutical And Biotechnology Company
6.7.2. Contract Research Organizations
6.7.3. Other End-Users
7. Major Market Trends
7.1. Introduction Of Cloud-Based Clinical Trial Platforms To Enable Easy Communication
7.2. Innovative Product Offerings To Clinical Trials With Advanced Data And Technology Platforms
7.3. Integration Of Real-World Evidence (RWE) Solutions, Pioneering Patient-Centric Advancements In Clinical Research And Digital Services
7.4. Strategic Partnerships And Collaborations To Develop New Products
7.5. Increasing Investments To Expand Digital Patient Engagement Programs
8. Artificial Intelligence (AI) In Clinical Trials Market - Macro Economic Scenario
8.1. COVID-19 Impact On The Artificial Intelligence (AI) In Clinical Trials Market
8.2. Impact Of The War In Ukraine On The Artificial Intelligence (AI) In Clinical Trials Market
8.3. Impact Of High Inflation On The Artificial Intelligence (AI) In Clinical Trials Market
9. Global Market Size and Growth
9.1. Market Size
9.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
9.2.1. Market Drivers 2017 – 2022
9.2.2. Market Restraints 2017 – 2022
9.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
9.3.1. Market Drivers 2022 – 2027
9.3.2. Market Restraints 2022 – 2027
10. Global Artificial Intelligence (AI) In Clinical Trials Market Segmentation
10.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
10.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
10.3. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
10.4. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
11. Artificial Intelligence (AI) In Clinical Trials Market, Regional and Country Analysis
11.1. Global Artificial Intelligence (AI) In Clinical Trials Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
11.2. Global Artificial Intelligence (AI) In Clinical Trials Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12. Asia-Pacific Market
12.1. Summary
12.1.1. Market Overview
12.1.2. Region Information
12.1.3. Market Information
12.1.4. Background Information
12.1.5. Government Initiatives
12.1.6. Regulations
12.1.7. Regulatory Bodies
12.1.8. Major Associations
12.1.9. Taxes Levied
12.1.10. Corporate Tax Structure
12.1.11. Investments
12.1.12. Major Companies
12.2. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.3. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.4. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.5. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis
12.6. China Market
12.7. Summary
12.7.1. Market Overview
12.7.2. Country Information
12.7.3. Market Information
12.7.4. Background Information
12.7.5. Government Initiatives
12.7.6. Regulations
12.7.7. Regulatory Bodies
12.7.8. Major Associations
12.7.9. Taxes Levied
12.7.10. Corporate Tax Structure
12.7.11. Investments
12.7.12. Major Companies
12.8. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.9. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.10. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.11. India Market
12.12. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.13. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.14. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.15. Japan Market
12.16. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.17. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.18. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.19. Australia Market
12.20. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.21. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.22. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.23. Indonesia Market
12.24. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.25. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.26. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.27. South Korea Market
12.28. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.29. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.30. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13. Western Europe Market
13.1. Summary
13.1.1. Market Overview
13.1.2. Region Information
13.1.3. Market Information
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulations
13.1.7. Regulatory Bodies
13.1.8. Major Associations
13.1.9. Taxes Levied
13.1.10. Corporate Tax Structure
13.1.11. Investments
13.1.12. Major Companies
13.2. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.3. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.4. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.5. Western Europe Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis
13.6. UK Market
13.7. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.8. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.9. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.10. Germany Market
13.11. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.12. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.13. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.14. France Market
13.15. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.16. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.17. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.18. Italy Market
13.19. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.20. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.21. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.22. Spain Market
13.23. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.24. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.25. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14. Eastern Europe Market
14.1. Summary
14.1.1. Market Overview
14.1.2. Region Information
14.1.3. Market Information
14.1.4. Background Information
14.1.5. Government Initiatives
14.1.6. Regulations
14.1.7. Regulatory Bodies
14.1.8. Major Associations
14.1.9. Taxes Levied
14.1.10. Corporate Tax Structure
14.1.11. Investments
14.1.12. Major Companies
14.2. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.3. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.4. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.5. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis
14.6. Russia Market
14.7. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.8. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.9. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15. North America Market
15.1. Summary
15.1.1. Market Overview
15.1.2. Region Information
15.1.3. Market Information
15.1.4. Background Information
15.1.5. Government Initiatives
15.1.6. Regulations
15.1.7. Regulatory Bodies
15.1.8. Major Associations
15.1.9. Taxes Levied
15.1.10. Corporate Tax Structure
15.1.11. Investments
15.1.12. Major Companies
15.2. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.3. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.4. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.5. North America Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis
15.6. USA Market
15.7. Summary
15.7.1. Market Overview
15.7.2. Country Information
15.7.3. Market Information
15.7.4. Background Information
15.7.5. Government Initiatives
15.7.6. Regulations
15.7.7. Regulatory Bodies
15.7.8. Major Associations
15.7.9. Taxes Levied
15.7.10. Corporate Tax Structure
15.7.11. Investments
15.7.12. Major Companies
15.8. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.9. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.10. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.11. Canada Market
15.12. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.13. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.14. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16. South America Market
16.1. Summary
16.1.1. Market Overview
16.1.2. Region Information
16.1.3. Market Information
16.1.4. Background Information
16.1.5. Government Initiatives
16.1.6. Regulations
16.1.7. Regulatory Bodies
16.1.8. Major Associations
16.1.9. Taxes Levied
16.1.10. Corporate Tax Structure
16.1.11. Investments
16.1.12. Major Companies
16.2. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.3. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.4. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.5. South America Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis
16.6. Brazil Market
16.7. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.8. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.9. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17. Middle East Market
17.1. Summary
17.1.1. Market Overview
17.1.2. Region Information
17.1.3. Market Information
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Major Associations
17.1.9. Taxes Levied
17.1.10. Corporate Tax Structure
17.1.11. Investments
17.1.12. Major Companies
17.2. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17.3. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17.4. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18. Africa Market
18.1. Summary
18.1.1. Market Overview
18.1.2. Region Information
18.1.3. Market Information
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Regulatory Bodies
18.1.8. Major Associations
18.1.9. Taxes Levied
18.1.10. Corporate Tax Structure
18.1.11. Investments
18.1.12. Major Companies
18.2. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18.3. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18.4. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
19. Competitive Landscape and Company Profiles
19.1. Company Profiles
19.2. Saama Technologies Inc.
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Performance
19.3. Trials.Ai
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Financial performance
19.4. Innoplexus AG
19.4.1. Company Overview
19.4.2. Products And Services.
19.4.3. Business Strategy
19.4.4. Financial performance
19.5. Deep 6 AI Inc
19.5.1. Company Overview
19.5.2. Products And Services.
19.5.3. Business Strategy
19.5.4. Financial performance
19.6. Unlearn.AI, Inc
19.6.1. Company Overview
19.6.2. Products And Services
19.6.3. Business Strategy
19.6.4. Financial performance
20. Key Mergers And Acquisitions
20.1. Recursion Acquired Cyclica and Valence
20.2. ZS Acquired Trials.ai
20.3. BioNTech Acquired InstaDeep
20.4. Beckman Coulter Diagnostics Acquired StoCastic, LLC
20.5. Bioclinica Acquired Saliency
21. Opportunities And Strategies
21.1. Global Artificial Intelligence (AI) In Clinical Trials Market In 2027 – Countries Offering Most New Opportunities
21.2. Global Artificial Intelligence (AI) In Clinical Trials Market In 2027 – Segments Offering Most New Opportunities
21.3. Global Artificial Intelligence (AI) In Clinical Trials Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Artificial Intelligence (AI) In Clinical Trials Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Geographies Covered
23.2. Market Data Sources
23.3. Research Methodology
23.4. Currencies
23.5. The Business Research Company
23.6. Copyright and Disclaimer

ページTOPに戻る

Table of Contents

Summary

Artificial Intelligence (AI) In Clinical Trials Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global artificial intelligence (AI) in clinical trials market as it emerges from the COVID-19 shut down.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and

Description:
Where is the largest and fastest growing market for artificial intelligence (AI) in clinical trials? How does the market relate to the overall economy, demography, and other similar markets? What forces will shape the market going forward? The artificial intelligence (AI) in clinical trials market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider artificial intelligence (AI) in clinical trials market; and compares it with other markets.

The report covers the following chapters.

• Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by offering, by process, by application and by end-user market.
• Key Trends
Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario
The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the artificial intelligence (AI) in clinical trials market.
• Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027, 2032F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis
Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region and country.
• Market Segmentation
Contains the market values (2017-2022) (2022-2027, 2032F) and analysis for each segment by offering, by process, by application and by end-user in the market. Historic (2017-2022) and forecast (2022-2027) and (2027-2032) market values and growth and market share comparison by region market.
• Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027,2032F) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations
This section includes recommendations for artificial intelligence (AI) in clinical trials providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:
1) By Offering: Software; Services
2) By Process: Trial Design; Patient Selection; Site Selection; Patient Monitoring
3) By Application: Oncology; Neurological Disease And Condition; Cardiovascular Disease; Metabolic Disease; Infectious Disease; Immunology Disease; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Company; Contract Research Organizations; Other End-Users

Companies Mentioned: Saama Technologies Inc.; Trials.Ai; Innoplexus AG; Deep 6 AI In; Unlearn.AI, Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; artificial intelligence (AI) in clinical trials indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（金融）の最新刊レポート

The Business Research Company　(TBRC) 社の最新刊レポート

本レポートと同じKEY WORD（artificial intelligence）の最新刊レポート

よくあるご質問

The Business Research Company　(TBRC)社はどのような調査会社ですか?

The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

臨床試験における人工知能（AI）の世界市場の機会と2032年までの戦略

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（金融）の最新刊レポート

The Business Research Company (TBRC) 社の最新刊レポート

本レポートと同じKEY WORD（artificial intelligence）の最新刊レポート

よくあるご質問

The Business Research Company (TBRC)社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

The Business Research Company　(TBRC) 社の最新刊レポート

The Business Research Company　(TBRC)社はどのような調査会社ですか?